Stock Information
symbol line chart

MTLSMaterialise Nv

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Wilfried Vancraen

Location

N/A, N/A

Exchange

Nasdaq

Website

https://materialise.com

Summary

Materialise NV provides additive manufacturing and medical software, and 3D printing services.

Company Info

CEO

Wilfried Vancraen

Location

N/A, N/A

Exchange

Nasdaq

Website

https://materialise.com

Summary

Materialise NV provides additive manufacturing and medical software, and 3D printing services.

AI Insights for MTLS
5 min read

Quick Summary

Materialise NV is a Belgium-based additive manufacturing and 3D printing company that provides software, medical solutions, and manufacturing services. The company operates through three main segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its software products help customers manage, prepare, optimize, and control 3D printing workflows across industrial and healthcare applications. Its medical business supports personalized healthcare by providing software, planning tools, and patient-specific implants, guides, and anatomical models used by surgeons, hospitals, and medical device companies. Its manufacturing business offers 3D printing services for prototyping, production parts, and customized components for industries such as healthcare, aerospace, automotive, consumer products, and industrial manufacturing. Major customers and collaborators include medical technology companies such as Zimmer Biomet, Johnson & Johnson’s DePuy Synthes, Medtronic, Abbott Laboratories, Corin, Mathys, and Encore Medical.

Strengths

•

Materialise’s primary strength is its diversified exposure to additive manufacturing through software, medical solutions, and manufacturing services.

•

This makes it more balanced than companies that depend primarily on selling 3D printers or materials.

•

The company has deep expertise in medical 3D printing, which is a high-value niche with demanding quality standards and meaningful barriers to entry.

•

Its collaborations with major medical technology companies give it credibility, distribution potential, and access to specialized healthcare use cases.

•

Materialise also benefits from long-term industry growth trends, including rapid prototyping, customized production, lightweight components, and digital manufacturing.

Key Risks

•

Materialise faces significant risks from valuation, competition, market cyclicality, and sector volatility.

•

The 3D printing industry has historically gone through waves of enthusiasm followed by disappointment, and investor sentiment can change quickly.

•

High interest rates or a weaker macroeconomic environment could reduce demand for growth stocks and pressure valuation multiples.

•

Industrial customers may delay additive manufacturing investments if economic uncertainty affects capital spending or production plans.

What to Watch

The financial snapshot supplied for this research is labeled Year 2026 and Quarter Q3, while the same dataset lists the next earnings date as August 27, 2026.
Because of that timing, the figures should be interpreted as the data provider’s latest available financial record rather than an independently confirmed full calendar Q3 earnings release.
Based on the supplied data, Materialise generated operating revenue of about 314.1 million, gross profit of about 179.5 million, operating income of about 10.5 million, and net income of about 9.1 million.
That implies a gross margin of roughly 57%, an operating margin of roughly 3%, and a net margin of roughly 3%, showing profitability but still relatively modest operating leverage.
The data also shows continued investment in the business, including about 54.1 million of research and development expense, about 72.3 million of marketing expense, and about 47.1 million of selling, general, and administrative expense.
No specific company-level event such as a new acquisition, major product launch, new contract win, regulatory approval, or newly announced partnership is identified in the provided quarter data.
The most concrete quarterly developments available from the dataset are therefore the profitability figures, the expense profile, the continued relevance of existing medical collaborations, and investor focus ahead of the listed next earnings date.

Price Drivers

•

Materialise’s stock price is likely driven by a combination of earnings performance, revenue growth, margin trends, valuation, and investor appetite for 3D printing exposure.

•

The company currently has positive net income of about 9.1 million and reported total revenue of about 314.1 million, which helps distinguish it from less profitable additive manufacturing companies.

•

However, its price-to-earnings ratio of about 44.7 and price-to-book ratio of about 6.7 suggest investors are already pricing in a meaningful amount of future growth.

•

The stock can also be affected by broader sentiment toward 3D printing, which has been volatile after years of hype, downturns, and renewed interest.

•

Industry growth forecasts showing long-term additive manufacturing expansion can support investor enthusiasm, but high interest rates and weak risk appetite can pressure valuation multiples.

•

Company-specific drivers include software growth, medical partnerships, manufacturing demand, operating leverage, cash flow conversion, and whether Materialise can prove that it deserves a premium valuation relative to peers.

Recent News

•

Recent news about Materialise and the 3D printing sector has been broadly constructive but still cautious.

•

Articles have noted that 3D printing stocks can rebound sharply when investor appetite for growth and manufacturing technology improves, but the sector remains volatile after years of uneven adoption and investor disappointment.

•

Materialise is often viewed as one of the more differentiated additive manufacturing names because it combines software, healthcare applications, and manufacturing services.

•

Industry coverage continues to emphasize applications in healthcare, aerospace, automotive, defense, construction, and industrial manufacturing.

•

The provided data does not identify a specific recent Materialise acquisition, controversy, or newly announced partnership, but it does show that the company remains tied to existing collaborations with major medical technology companies.

Market Trends

•

The broader additive manufacturing market is expected to grow over the next decade, which is supportive for Materialise.

•

Key growth drivers include rapid prototyping, on-demand manufacturing, lightweight parts, mass customization, medical personalization, and decentralized production.

•

Healthcare, aerospace, automotive, defense, and industrial manufacturing are among the most important end markets for adoption.

•

Important technology trends include AI-assisted design, generative design, multi-material printing, sustainable materials, robotics, smart factories, and production-scale additive manufacturing.

•

At the same time, the industry still faces challenges such as high equipment costs, limited materials, slower mass production compared with traditional manufacturing, standardization issues, and intellectual property risks.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on MTLS

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show